SCHEMBL219819

SCHEMBL219819

OCCC1CNCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4749933 1.00
SCHEMBL4743019 1.00
Hydrochloric Acid SCHEMBL30460597 0.98 CXCR4 (0.38)
Hydrochloric Acid SCHEMBL22122712 0.98 CXCR4 (0.38)
Piperazine SCHEMBL10385674 0.98 CXCR4 (0.41)
SCHEMBL9484397 0.98 CXCR4 (0.41)
SCHEMBL1408398 0.86 CXCR4 (0.44)
SCHEMBL2916370 0.86 CXCR4 (0.47)
SCHEMBL19878848 0.86 CXCR4 (0.47)
SCHEMBL28767292 0.85 CXCR4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109928402-B Preparation method of SAPO-34 molecular sieve, acid catalyst and catalyst for reaction for preparing olefin by converting oxygen-containing compound 中国科学院大连化学物理研究所 2021-05-25 CN claimed
CN-109928402-A The catalyst of the preparation method of SAPO-34 molecular sieve, acid catalyst and oxygenate conversion olefine reaction 中国科学院大连化学物理研究所 2019-06-25 CN claimed
CN-101362986-B Aqueous phase cleaning composition for semiconductor copper processing CABOT MICROELECTRONICS CORP 2012-09-05 CN claimed
EP-2162431-A2 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2010-03-17 EP claimed
CN-101362986-A Aqueous phase cleaning composition for semiconductor copper processing EPOCH MATERIAL CO LTD (CN) 2009-02-11 CN claimed
WO-2009005676-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2009-01-08 WO claimed
EP-1994024-A2 QUINOLINE DERIVATIVES AstraZeneca AB (SE) 2008-11-26 EP claimed
EP-1994025-A1 QUINOLINE DERIVATIVES AstraZeneca AB (SE) 2008-11-26 EP claimed
WO-2007099323-A2 QUINOLINE DERIVATIVES ASTRAZENECA AB (SE) 2007-09-07 WO claimed
WO-2007099326-A1 QUINOLINE DERIVATIVES ASTRAZENECA AB (SE) 2007-09-07 WO claimed
EP-1140860-A1 PYRIMIDINE COMPOUNDS AstraZeneca AB (SE) 2001-10-10 EP claimed
WO-2001027089-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2001-04-19 WO claimed
EP-1077931-A1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES AstraZeneca AB (SE) 2001-02-28 EP claimed
WO-2000055120-A1 AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2000-09-21 WO claimed
WO-2000053595-A1 PYRIMIDINE COMPOUNDS ASTRAZENECA AB (SE) 2000-09-14 WO claimed
WO-2000039101-A1 PYRIMIDINE COMPOUNDS ASTRAZENECA AB (SE) 2000-07-06 WO claimed
WO-1999059959-A1 BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES ASTRAZENECA AB (SE) 1999-11-25 WO claimed
EP-0122151-B1 PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE MEITO SANGYO KABUSHIKI KAISHA (JP) 1989-02-15 EP claimed
US-4783402-A Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1988-11-08 US claimed
EP-0122151-A2 Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1984-10-17 EP claimed